AstraZeneca Has Stake In Three Of Nine NCATS Research Projects
This article was originally published in The Pink Sheet Daily
Executive Summary
Nine NIH National Center for Advancing Translational Sciences research projects involving repurposed investigational drugs will be funded with a total of $12.7 million and cover eight disease areas. In addition to AstraZeneca, compounds provided by Pfizer, Sanofi, Lilly and Janssen will be studied.